Pfizer’s “Swift Response” To Neurontin Generics Gives Greenstone 23% Share
Executive Summary
Pfizer's Greenstone division held nearly a quarter of the generic gabapentin market share four days after the launch of AB-rated versions of Neurontin, Teva said in court filings
You may also be interested in...
Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says
Pfizer sees no need for significant changes to its sales force model for at least the next three to five years, CEO Hank McKinnell said Jan. 19
Pfizer Sales Force Is “Critical” To Five-Year Strategy, McKinnell Says
Pfizer sees no need for significant changes to its sales force model for at least the next three to five years, CEO Hank McKinnell said Jan. 19
Pfizer Lyrica Launch Awaits Controlled Substance Scheduling
Pfizer's launch of Lyrica will be delayed while pregabalin undergoes controlled substance scheduling at the Drug Enforcement Administration